Updated Jul 16, 2026
Marshall Richard Henry has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Marshall Richard Henry is a physician-executive who serves as Chief Medical Officer of TriSalus Life Sciences, Inc. In this role, he is responsible for medical strategy and clinical development at the company. Public SEC filings as of 2026-06-29 identify him specifically as TriSalus Life Sciences’ Chief Medical Officer but do not disclose additional biographical details such as education, prior positions, or career history.
| Role | Chief Medical Officer |
|---|---|
| Notability | 48/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-29 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 60.0K | $0.00 |
Marshall Richard Henry is a physician-executive who serves as Chief Medical Officer of TriSalus Life Sciences, Inc. In this role, he is responsible for medical strategy and clinical development at the company. Public SEC filings as of 2026-06-29 identify him specifically as TriSalus Life Sciences’ Chief Medical Officer but do not disclose additional biographical details such as…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Marshall Richard Henry profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.